Cue Health Intrinsic Value – Investors of Cue Health Urged to Investigate Potential Legal Claims
April 28, 2023
Trending News ☀️
Investors of Cue Health ($NASDAQ:HLTH) Inc. have been urged to investigate potential legal claims. Cue Health Inc. is a publicly traded healthcare technology company, focused on providing early detection and monitoring of infectious diseases. The Schall Law Firm, a nationally renowned firm specializing in shareholder rights litigation, is conducting an investigation into potential claims on behalf of investors of Cue Health Inc. The investigation is related to whether the company has violated the federal securities laws or breached its fiduciary duties to its shareholders. The investigation focuses on whether the company and/or its officers and directors have misled investors by making false and/or misleading statements and/or failed to disclose material information about its business, operations and prospects.
The firm seeks to determine whether Cue Health Inc. has violated the federal securities laws and/or breached its fiduciary duties to its shareholders. The firm has represented many investors who have suffered financial losses due to corporate wrongdoing.
Stock Price
According to data, the stock opened at $0.9 and closed at $0.8, much lower than its last closing price of 0.9. This significant drop in stock prices could indicate a potential legal issue that investors should look into more closely. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cue Health. More…
| Total Revenues | Net Income | Net Margin |
| 474.17 | -194.06 | -40.5% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cue Health. More…
| Operations | Investing | Financing |
| -111.92 | -63.03 | -6.43 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cue Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 694.58 | 118.09 | 3.83 |
Key Ratios Snapshot
Some of the financial key ratios for Cue Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 315.2% | – | -42.8% |
| FCF Margin | ROE | ROA |
| -36.9% | -21.8% | -18.3% |
Analysis – Cue Health Intrinsic Value
At GoodWhale, we have conducted an analysis of CUE HEALTH‘s financials and our proprietary Valuation Line has determined the fair value of CUE HEALTH share to be around $4.2. However, the current price of the stock is only $0.8, which represents an undervaluation of 80.8%. This presents a great opportunity for investors to take advantage of the mispricing and reap the potential rewards that a share in CUE HEALTH can bring. More…
Peers
The healthcare industry is intensely competitive, with companies vying for market share in a variety of ways.
– Galileo Life Sciences Inc ($OTCPK:MDRM)
Galileo Life Sciences Inc is a publicly traded company with a market capitalization of 2.93M as of 2022. The company’s return on equity, a measure of profitability, is 199.87%. Galileo Life Sciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for the treatment of cancer and other serious diseases. The company’s lead product candidate is a small molecule inhibitor of the PI3K/mTOR pathway, which is in clinical development for the treatment of advanced solid tumors.
– Privia Health Group Inc ($NASDAQ:PRVA)
Privately held Privia Health Group, Inc. is a national physician organization that partners with hospitals, health plans, and health systems to improve clinical and financial outcomes. The company provides a range of services, including population health management, care coordination, and revenue cycle management. Privia also offers a suite of technology solutions to help its partners deliver high-quality, cost-effective care.
– LifeStance Health Group Inc ($NASDAQ:LFST)
LifeStance Health Group Inc is a healthcare company with a focus on mental health and addiction. The company has a market cap of 2.92B as of 2022 and a Return on Equity of -14.92%. The company’s main offerings include outpatient mental health services, residential treatment facilities, and recovery support services. The company has been operational for over 20 years and has a presence in multiple states across the US.
Summary
Investors of Cue Health Inc should be aware of the potential risks associated with investing in the company. The Schall Law Firm has recently announced an investigation of potential claims made by Cue Health Inc’s shareholders, which caused the stock price to move down the same day. Although the investigation may not lead to anything, investors should do their own due diligence and research before investing in this company. It is important to understand the financial risks and rewards associated with any investment, and to be aware of any developments that may affect the company’s performance in the future.
